文献速递妇科

PD-1基因多态性对上皮性卵巢癌发病风险及患者结局的影响

The effect of polymorphisms in PD-1 gene on the risk of epithelial ovarian cancer and patients' outcomes.
PubMed 文献 · Gynecol Oncol · 2016-11-09

在中国北方女性中开展病例对照研究,纳入620例上皮性卵巢癌(EOC)患者和620例对照女性,其中258例接受铂类化疗的患者有生存数据。PD-1.1 A/G的基因型和等位基因分布频率在两组间有显著差异,AG和GG基因型较AA基因型可显著降低EOC发病风险;PD-1.5 C/T的基因型分布频率无显著差异,但T等位基因频率在EOC患者中显著低于对照,携带T等位基因者发病风险显著降低。生存分析显示两种多态性与患者结局无关。

要点

  • PD-1.1 A/G的基因型和等位基因分布频率在EOC患者与对照间有显著差异(P=0.028和P=0.02)。
  • PD-1.1 AG和GG基因型较AA基因型可显著降低EOC发病风险(OR=0.71和OR=0.68)。
  • PD-1.5 C/T的基因型分布频率无显著差异(P=0.096),但T等位基因频率在EOC患者中显著低于对照(P=0.033)。

核心结论

  • PD-1基因多态性可能参与中国北方女性EOC的发生,但与EOC患者的临床结局无关。

研究设计与样本

  • 病例对照研究,纳入620例EOC患者和620例对照女性,其中258例接受铂类化疗后有生存数据。

主要发现

  • PD-1.1 A/G的基因型和等位基因分布频率在EOC患者与对照间有显著差异(P=0.028和P=0.02)。
  • 与AA基因型相比,AG和GG基因型可能显著降低EOC发病风险(OR=0.71,95%CI=0.54-0.94;OR=0.68,95%CI=0.50-0.94)。
  • PD-1.5 C/T的基因型分布频率在EOC患者与对照间无显著差异(P=0.096),但T等位基因频率在EOC患者中显著低于对照(P=0.033)。
  • 与携带C等位基因者相比,携带T等位基因者EOC发病风险显著降低(OR=0.82,95%CI=0.69-0.98)。
  • 生存分析显示两种多态性与患者结局无关。

关键数值与推荐

  • PD-1.1 A/G基因型和等位基因分布频率在EOC患者与对照间差异有统计学意义(P=0.028和P=0.02)。
  • 与AA基因型相比,AG基因型OR=0.71(95%CI=0.54-0.94),GG基因型OR=0.68(95%CI=0.50-0.94)。
  • PD-1.5 C/T基因型分布频率在EOC患者与对照间差异无统计学意义(P=0.096),T等位基因频率在EOC患者中显著低于对照(P=0.033)。
  • 与携带C等位基因者相比,携带T等位基因者OR=0.82(95%CI=0.69-0.98)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Programmed death-1 (PD-1), an important immunosuppressive molecule, plays a key role in tumor-cell-mediated immune escape. In the present study, we evaluated the effect of PD-1 gene polymorphisms on the risk of developing epithelial ovarian cancer (EOC) and patients' outcomes. METHODS: A case-control study was performed in 620 EOC patients and 620 control women. Survival data were available for 258 patients who received platinum-based chemotherapy after cytoreductive surgery. RESULTS: There were significant differences in the genotype and allele distribution frequencies of the PD-1.1 A/G between cases and controls (P=0.028 and P=0.02, respectively). Compared with the AA genotype, AG and GG genotypes may significantly decrease the risk of developing EOC (OR=0.71, 95%CI=0.54-0.94; OR=0.68, 95%CI=0.50-0.94, respectively). We did not find a significant difference in the genotype distribution frequency of the PD-1.5 C/T between cases and controls (P=0.096), but the frequency of T alleles was significantly lower in the EOC cases than that in the controls (P=0.033). Compared to the carriers with C alleles, the carriers with T alleles were at a significantly decreased risk of developing EOC (OR=0.82, 95%CI=0.69-0.98). Survival analysis showed that the two polymorphisms were not associated with patients' outcomes. CONCLUSIONS: PD-1 gene polymorphisms may be involved in the development of EOC, but not associated with its clinical outcome in EOC patients among northern Chinese women.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Li Y, Zhang HL, Kang S, et al. The effect of polymorphisms in PD-1 gene on the risk of epithelial ovarian cancer and patients' outcomes. Gynecol Oncol. 2016. PMID: 27836206. doi:10.1016/j.ygyno.2016.11.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。